Raised S.B. No. 415
Session Year 2022
 


AN ACT CONCERNING STEP THERAPY, ADVERSE DETERMINATION AND UTILIZATION REVIEWS.

To (1) prohibit certain health carriers from requiring the use of step therapy for drugs prescribed to treat behavioral health conditions or chronic, disabling or life-threatening conditions or diseases; (2) redefine "clinical peer" for the purposes of adverse determination and utilization reviews; (3) require health carriers to bear the burden of proving that certain health care services under adverse determination or utilization review are not medically necessary; and (4) require health carriers to provide certain clinical peers with authority to reverse initial adverse determinations.

Introduced by:
Insurance and Real Estate Committee

 New today  2-4 days old  5 days & older
   Text of Bill
 Raised Bill  [doc]
  View or Add Notes to SB-415

Add Notes to SB-415

Go To My Bills


This bill is in My Bills.
Do you wish to go to My Bills?

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 3/11/2022Public Hearing 03/17
 3/10/2022Referred to Joint Committee on Insurance and Real Estate

Co-sponsors of SB-415

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.